# K991123: Perfecta RS Lateralized Hip Stem, Bridge Hip System

- Pathway: 510(k) (Abbreviated)
- Applicant: Wrightmedicaltechnologyinc
- Decided: Jun 1, 1999 after 60 days
- Product code: LPH (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented)
- Device class: 2
- Regulation: 21 CFR 888.3358
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
6 later devices descend from it; 2 cite it directly.
0 of 7 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) Dual Offset PERFECTA® IMC Hip Stem: named in the summary without a submission number
- (no number) BRIDGE® Hip System: named in the summary without a submission number

## Most influential descendants
- K061344: Excia Total Hip System Lateral Offset (2006), 4 descendants of its own
- K092143: Excia Total Hip System M an ML Femoral Stem (2009), 3 descendants of its own
- K140915: Excia Total Hip System (2014), 2 descendants of its own
- K150062: Excia Total Hip System (2015), 1 descendant of its own
- K172235: CoreHip® System (2018), 0 descendants of its own

## Indications for use
This device is indicated in total hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions: Non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, ankylosis, protrusio acetabuli, and painful hip dysplasia; Inflammatory degenerative joint disease such as rheumatoid arthritis; Correction of function deformity; Revision procedures where other treatments or devices have failed; and Treatment of nonunion, femoral neck, and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques.

Source page: https://510kreport.com/device/K991123
Methodology: https://510kreport.com/methodology